Glaxosmithkline Pharmaceuticals consolidated net profit rises 9.25% in the June 2021 quarter
Sales rise 21.80% to Rs 789.99 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 9.25% to Rs 121.08 crore in the quarter ended June 2021 as against Rs 110.83 crore during the previous quarter ended June 2020. Sales rose 21.80% to Rs 789.99 crore in the quarter ended June 2021 as against Rs 648.59 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales789.99648.59 22 OPM %19.2017.59 -PBDT182.61170.91 7 PBT164.90149.14 11 NP121.08110.83 9Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jul 27 2021 | 8:00 AM IST